Grants Search Results

Although most kids with a brain tumor survive the tumor itself, many have trouble doing activities that require attention and memory, and they often have difficulty fitting in with peers. Both types of difficulty could be related to changes in their brain structure or function, but research on this hasn'’t been done yet. Dr. Hoskinson is looking at whether there's a connection between these changes in brain structure and function and how kids get along with their peers. If there is, this research aims to help predict which kids will have social problems after treatment and identify ways to help.

This grant helps provide necessary resources to support the Survivorship Clinic, and to study, through increased clinical trial enrollment, the late effects of recently treated children.

This grant provides resources to help build an AYA Survivorship Program, to ensure that more adolescents and young adults can be treated on clinical trials, and to provide survivorship planning.

This grant funds a Clinical Research Associate to further develop and enhance the survivor program and develop effective outreach to this population.

This grant provides resources to establish a soft tissue sarcoma subspecialty team to improve patient outcomes and ensure the best transition for adults from pediatric survival clinic to adult care.

This grant helps provide necessary resources for the Childhood Cancer Survivorship Program at this institution, enhancing research while providing childhood cancer survivors the support, treatment and education they need to prevent and address late effects.

This grant funds the sustainability of a comprehensive long-term follow-up program and expansion plans to create a transition program with the goal to monitor the medical and psychosocial issues that young cancer patients face as they enter into adulthood.

Brain tumors are the most common solid cancer in children, and are often cured with radiation therapy. While radiation attacks the tumor, it can also leave the child with significant learning problems that affect their quality of life over the many years following cancer. Dr. Castellino focuses on understanding how heart function and brain vessel function may have been affected during treatment of the brain tumor. The goal of this research is to create strategies to prevent or lessen the injury to the brain during treatment, not only to cure the cancer in children, but also to preserve normal function for productive and healthy lives as cancer survivors.

Nutrition experts recommend that pediatric cancer survivors eat more fruits, vegetables, and whole grain products, and to lead active lifestyles. However, studies suggest that childhood cancer survivors are at risk for excessive weight gain and poor fitness. Strategies to enhance the nutritional quality of diets and to promote physical activity among cancer survivors are greatly needed. This study assesses the feasibility of healthy lifestyle coaching by group televideo conferencing to encourage healthy lifestyle modifications.

Children treated with bone marrow transplant (HSCT) for high-risk leukemia are at risk for late effects of treatment that can significantly impact their quality of life and survival. There are very few multi-center studies of these toxicities. This consortium studies organ-specific late effects, tests a screening regimen, and investigates biomarkers of disease in survivors of pediatric HSCT. The goals of this project are to better understand, prevent, and treat late effects of childhood transplant resulting in improved long-term survival. Funds administered by Dana-Farber Cancer Institute.

This institution is a member of a research consortium which is being funded by St. Baldrick's: PBMTC Late Effects Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: PBMTC Late Effects Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: PBMTC Late Effects Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: PBMTC Late Effects Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: PBMTC Late Effects Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: PBMTC Late Effects Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: PBMTC Late Effects Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: PBMTC Late Effects Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: PBMTC Late Effects Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: PBMTC Late Effects Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.